These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 19663194)
1. [Content of C-reactive protein, interleukin-1, interleukin-6 and interleukin-1 receptor antagonist in the blood of patients with early osteoarthrosis of the knee joints]. Svetlova MS; Vezikova NN; Romashina VV; Sobanina TS; Pavlov IuL; Chepliukova IA Ter Arkh; 2009; 81(6):52-6. PubMed ID: 19663194 [TBL] [Abstract][Full Text] [Related]
2. [Clinical, instrumental, and laboratory characteristics of early stages of gonarthrosis]. Svetlova MS; Vezikova NN Ter Arkh; 2010; 82(5):54-8. PubMed ID: 20597272 [TBL] [Abstract][Full Text] [Related]
3. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]. Peng Q; Wu Q; Chen CH; Hong H; Zhang LY Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593 [TBL] [Abstract][Full Text] [Related]
4. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233 [TBL] [Abstract][Full Text] [Related]
5. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer. Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411 [TBL] [Abstract][Full Text] [Related]
6. [Cartilage oligomeric matrix protein, a possible marker of synovitis in early knee joint osteoarthrosis]. Svetlova MS; Vezikova NN; Romashina VV; Sobanina TS; Pavlov IuL; Chepliukova IA Klin Med (Mosk); 2008; 86(11):65-8. PubMed ID: 19177799 [TBL] [Abstract][Full Text] [Related]
7. A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis. Richette P; François M; Vicaut E; Fitting C; Bardin T; Corvol M; Savouret JF; Rannou F J Rheumatol; 2008 Aug; 35(8):1650-4. PubMed ID: 18597398 [TBL] [Abstract][Full Text] [Related]
8. [Clinical and laboratory features of different forms of osteoarthrosis]. Artemenko NA; Chvamaniia MO Klin Med (Mosk); 2009; 87(2):45-50. PubMed ID: 19348302 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis. Pietruczuk A; Swierzbińska R; Pancewicz S; Pietruczuk M; Hermanowska-Szpakowicz T Infection; 2006 Jun; 34(3):158-62. PubMed ID: 16804660 [TBL] [Abstract][Full Text] [Related]
10. Pituitary-gonadal hormones and interleukin patterns in leprosy. Leal AM; Magalhães PK; Souza CS; Foss NT Trop Med Int Health; 2006 Sep; 11(9):1416-21. PubMed ID: 16930264 [TBL] [Abstract][Full Text] [Related]
11. Systemic and local cytokine kinetics after total hip replacement surgery. Bastian D; Tamburstuen MV; Lyngstadaas SP; Reikerås O Eur Surg Res; 2008; 41(4):334-40. PubMed ID: 18815447 [TBL] [Abstract][Full Text] [Related]
12. The effect of flurbiprofen and tiaprofenic acid on serum cytokine levels of patients with osteoarthrosis. Uzun H; Tuzun S; Ozaras N; Aydin S; Ozaras R; Dondurmaci S; Tuzun F Acta Orthop Scand; 2001 Oct; 72(5):499-502. PubMed ID: 11728078 [TBL] [Abstract][Full Text] [Related]
13. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children. Sikora JP; Kuzański W; Andrzejewska E Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968 [TBL] [Abstract][Full Text] [Related]
14. Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. Luotola K; Pietilä A; Zeller T; Moilanen L; Kähönen M; Nieminen MS; Kesäniemi YA; Blankenberg S; Jula A; Perola M; Salomaa V; J Intern Med; 2011 Mar; 269(3):322-32. PubMed ID: 21205020 [TBL] [Abstract][Full Text] [Related]
15. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Orre IJ; Murison R; Dahl AA; Ueland T; Aukrust P; Fosså SD Brain Behav Immun; 2009 Aug; 23(6):868-74. PubMed ID: 19362138 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer. Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321 [TBL] [Abstract][Full Text] [Related]
17. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males. Ovaskainen Y; Koponen H; Jokelainen J; Keinänen-Kiukaanniemi S; Kumpusalo E; Vanhala M Psychiatry Res; 2009 May; 167(1-2):73-9. PubMed ID: 19346005 [TBL] [Abstract][Full Text] [Related]
18. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure]. López L; Arai K; Giménez E; Jiménez M; Pascuzo C; Rodríguez-Bonfante C; Bonfante-Cabarcas R Rev Esp Cardiol; 2006 Jan; 59(1):50-6. PubMed ID: 16434004 [TBL] [Abstract][Full Text] [Related]
19. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion. Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929 [TBL] [Abstract][Full Text] [Related]
20. [Assessment of changes in levels of interleukin 6 and C reactive protein in patients with breast tumors]. Zakrzewska I; Kozłowski L; Wojtukiewicz M Pol Merkur Lekarski; 2003 Aug; 15(86):115-7. PubMed ID: 14648971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]